increased long-term risk of breast cancer with high intra-tumour er hetrogeneity
Published 7 years ago • 917 plays • Length 4:34Download video MP4
Download video MP3
Similar videos
-
53:45
intra-tumor heterogeneity and drug response
-
2:35
breast cancer heterogeneity
-
1:06:01
heterogeneity of breast cancer genomes
-
5:15
decode heterogeneity with the breast cancer 360 panel
-
11:30
single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity
-
1:34
tumor heterogeneity in breast cancer | rtcl.tv
-
7:38
long-term breast cancer risk after benign breast disease in population-based screening
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
2:28
how estrogen increases the risk of breast cancer
-
34:42
addressing the challenge of her2 heterogeneity in breast cancer
-
22:51
mht use for cancer survivors
-
1:09:19
lmp: breast cancer inter- and intra- tumor genetic hetrogeneity - jorge reis filho m.d., ph.d.
-
1:03:08
vtlss: evolving concepts of breast heterogeneity and impacts on tumor/metastasis characterization
-
1:00:42
her2 breast cancer deep dive into the science behind the treatment
-
8:15
impakt 2013: long-term effectiveness of serms for preventing breast cancer
-
1:49
early breast cancer: do we need chemotherapy in low genomic/high clinical risk (er /her2-)?
-
2:55
differential long-term benefit of adjuvant tamoxifen in er /her2- premenopausal postmenopausal bc
-
1:36
dr. cuzick on decreasing breast cancer risk with tamoxifen
-
7:04
treatment for early-stage er breast cancer